C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
167/202, 260/210
C07H 17/08 (2006.01) A01N 43/90 (2006.01) A01N 55/00 (2006.01) A61K 31/70 (2006.01) C07H 19/01 (2006.01) C07H 23/00 (2006.01)
Patent
CA 2017030
Abstract Novel compounds of formula (I): Image (I) wherein R1 is hydrogen or optionally protected hydroxy; R2 is alkoxy, optionally protected hydroxy, oxo or optionally O-substituted oximino; R3 is hydrogen, optionally protected hydroxy,or a group 4'-(.alpha.-L-oleandrosyl)-.alpha.-L-oleandrosyloxy or .alpha.-L- oleandrosyloxy wherein the terminal hydroxy group is optionally protected; R4, R5, R6 and R7 are the same or different and each is hydrogen or an organic radical; and R8 is an optionally substituted amino or imino group such as optionally O-substituted oxyimino, optionally N-substituted hydrazone, or optionally N-substituted semicarbazone; are useful in the treatment of helminthiasis in humans and animals.
Baker Geoffrey H.
Blanchflower Simon E.
Dorgan Roderick J.
Morgan David O.
Shelley Peter R.
Borden Ladner Gervais Llp
Limited Pfizer
LandOfFree
Derivatives of milbemycins and avermectins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of milbemycins and avermectins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of milbemycins and avermectins will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1695740